A patient of mine came in last fall, not for a consultation about his hip, but to ask me about peptides. He’d been injecting BPC-157 he ordered online for three months. No prescription. No oversight. No idea what he was actually putting in his body.

He wasn’t reckless. He was desperate. Chronic tendon pain, slow recovery, a body that wasn’t doing what it used to. He’d read the forums, watched the videos, and decided to act. I respected that instinct, even as I sat across from him calculating the risk he’d taken.

That conversation is happening everywhere right now. In clinics. In gyms. In group chats between people who are tired of feeling like their doctors have no answers. And most of the time, nobody is giving a straight answer.

I will.

The Biology Is Real. The Market Is Chaos.

Let me be clear about something first: peptides are not fringe science.

Insulin is a peptide. You know insulin. Semaglutide, the active compound in Ozempic and Wegovy, is a peptide. It just reshaped the global conversation about obesity. The FDA’s approval of the first oral semaglutide tablet for chronic weight management in late 2025 didn’t happen because molecules like this are unproven novelties. It happened because peptide biology, at the right end of the research spectrum, is some of the most precise and powerful pharmacology we have.

A peptide is a chain of amino acids, shorter than a protein, which makes it more targeted in function. These molecules act as biological messengers, instructing specific cells to perform specific tasks. Your body already produces thousands of them. The therapy argument is simple: can we supplement with synthetic versions to restore processes that slow with age or stress?

In some cases, yes. In many cases, we do not yet know. And that gap is where everything goes wrong.

Where the Science Ends and the Hype Begins

Here is the distinction that most of the wellness industry refuses to make clearly, so I will make it for you.

There are FDA-approved peptides with rigorous human trial data, clear mechanisms, and established safety profiles. Then there is a much larger category of peptides that are biologically plausible, show promising results in animal models, and are being injected by thousands of people with zero physician involvement, based on forum posts and influencer content.

Online peptide advertising increased 678% between 2022 and 2025 as GLP-1 drugs gave the entire category mainstream credibility by association.¹ If semaglutide, a peptide, could do what Ozempic does, the logic went, what else might these molecules be capable of? That halo effect drove enormous interest straight into the gray market, and straight into people’s bodies.

BPC-157 is the most visible example of what that looks like when it goes wrong. It is arguably the most popular peptide in the biohacking world. People are injecting it for tendon repair, gut health, and injury recovery. As of early 2026, **35 of 36 published BPC-157 studies are animal-only, sourced from a single lab with undisclosed conflicts of interest.**² The enthusiasm for this compound ran years ahead of the evidence. That is not a minor detail. That is the entire story.

The delivery problem compounds this. Most peptides break down in the digestive tract. Serious use cases require injection, which means sourcing, sterility, accurate dosing, and proper technique all become critical variables. When people are ordering compounds from gray-market vendors with no clinical oversight, every one of those variables is out of control.

The gap between “makes sense in theory” and “proven safe in humans” is vast. I have spent my career on the side of that gap that requires evidence before action. I am not moving.

The Regulatory Reckoning Was Inevitable

The FDA’s posture toward compounded peptides shifted hard in late 2023, and by 2025 it had become a full enforcement campaign. More than 50 warning letters issued to compounders, online sellers, and clinics. Criminal prosecutions. Raids on major gray-market vendors.

The DOJ forced Tailor Made Compounding LLC to forfeit $1.79 million, establishing that the federal government was willing to bring criminal charges, not just civil penalties.³ Peptide Sciences, one of the largest gray-market players, voluntarily shut down in March 2026 before the walls closed in.

The political dimension added one more layer. RFK Jr. publicly pushed the FDA to widen access, calling himself a fan of peptide treatments and signaling that roughly 14 peptides should be made more accessible through compounding pharmacies. The enforcement machine didn’t pause.

But what the political conversation did do, and this matters for everyone following this space, is force a legitimate question onto the table: should patients have a supervised, physician-guided pathway to promising compounds that sit outside the current approval framework?

That is a reasonable question. It deserves a serious answer. Not a gray market, and not a blanket ban.

The crackdown was necessary. Not because the underlying biology is fraudulent. But because access without oversight is not freedom. It is exposure.

What I Actually Believe

I am not here to bury peptides. I am here to be precise about them, because precision is what this conversation has been missing.

The legitimate end of this science is advancing fast. AI-assisted peptide design accelerated discovery pipelines dramatically in 2025. Cancer therapies, metabolic interventions, immune modulation, these are real frontiers with real rigor behind them. The biology deserves serious investment and serious research. And patients deserve physicians who are engaged with it, not dismissive of it.

Here is the framework I use for any emerging intervention, whether it is a peptide, a surgical technology, or a wellness protocol. It applies whether you are a clinician evaluating options or a patient trying to make a smart decision about your own body:

1. What is the evidence hierarchy? Human trials, animal models, and in-vitro data are not equivalent. Know which one you are standing on before you act.

2. Who is prescribing and who is sourcing? A compounding pharmacy with a physician-supervised protocol is not the same as a gray-market vendor and a self-injection tutorial.

3. What is the risk-benefit calculation for this specific person? Not the population. Not the forum. You, your biology, your context.

4. What is the baseline? No peptide, drug, or technology outperforms a life built on sleep, whole food nutrition, consistent movement, and stress management. That is not a platitude. It is the highest-leverage intervention available to every human being on this planet, and it costs nothing.

The Foundation Always Comes First

I have performed over 10,000 joint replacements. I have watched patients spend years treating symptoms that were the direct consequence of how they lived, how they ate, how much they slept, and how much they moved. And I have watched those same patients expect a molecule to fix what decades of lifestyle built.

It won’t.

The most powerful intervention in human health is still the one that requires the most discipline: prevention. Real food. Real sleep. Real movement. Real relationships. These are not soft suggestions. They are the clinical foundation without which medicine, including the most advanced peptide therapies, is always playing catch-up.

My patient who had been injecting BPC-157 for three months had never had a serious conversation with a physician about his diet, his sleep quality, or his inflammatory load. He went straight to the injection because it felt like action. I understand that impulse completely. People are tired of waiting for the system to give them better options.

But here is what I told him, and what I will say plainly here: action without a foundation is just noise.

If you are curious about peptides, that curiosity is legitimate. The biology is real. The potential is real. But find a physician who will engage with you seriously, demand to know where you are in the evidence hierarchy, and build the lifestyle foundation that makes any intervention actually work.

The shortcut culture that drove the gray market is the same culture that has people spending thousands of dollars on compounds while sleeping five hours a night and eating ultra-processed food.

The molecule is not going to save you from that. Nothing is.

The Bottom Line

We are in an era where the biology of human optimization is genuinely accelerating. The tools are getting more precise. The research is getting more sophisticated. Patients are more informed and more engaged than any generation before them. That is something to build on, not shut down.

The surgeon’s job, and every physician’s job, is to stand at the incision point: where intention meets reality, where the plan meets the patient in front of you. That means demanding evidence, providing real oversight, and being honest when the shortcut isn’t actually shorter.

The molecule is not the enemy. The shortcuts are.

Are you navigating peptide questions as a patient, a clinician, or both? I’d like to hear what you’re seeing, and what answers you’re still looking for.

Footnotes

1. PeptideExaminer, Online Peptide Market Growth Analysis, 2025.

2. STAT News / PeptideExaminer, BPC-157 Research Landscape Review, February 2026.

3. U.S. Department of Justice, United States v. Tailor Made Compounding LLC, 2025.

My patients don’t just come to me in pain.

They come to me exhausted. They come with type 2 diabetes, hypertension, and a knee that gave out, managing three chronic conditions at 55 that their parents didn’t have at 70.

They come having done, more or less, what they were told. They bought what was on the grocery shelf. They ate what was affordable. They fed their kids what was available at the school cafeteria and the drive-through and the gas station on the way home from work.

And somewhere in that chain of ordinary decisions, something went very wrong.

I trained at Mayo Clinic. I hold an engineering degree from Rose-Hulman. I have performed more than 10,000 joint replacements. I have sat on the boards of the largest orthopedic surgery organizations in the world. I see the consequences of the American food system in the operating room every single week.

What I see is not bad luck. It is not genetics. It is the predictable, documented, and entirely preventable result of a food supply that has been engineered for profit at the direct expense of human health, for decades, with the full knowledge of the people doing it.

I am done softening that statement.

What Is Actually In Your Food

American adults now get 53% of their daily calories from ultra-processed foods. For children, that number is 62%.[1] The CDC confirmed these figures in its first-ever report on the subject, published in August 2025. First-ever. We have known this was happening for years and the federal government only just got around to measuring it officially.

More than half your calories. Every day. From products that bear almost no resemblance to food in any meaningful biological sense.

I want to be specific, because “ultra-processed” is a term that lets the industry hide behind abstraction. Here is what it actually means: these are industrial formulations containing ingredients that did not exist in the human food supply until the 20th century and whose long-term biological effects were never independently verified before they were put in everything you eat.

Petroleum-derived synthetic dyes: Red No. 40, Yellow No. 5, Yellow No. 6, Blue No. 1. Added to thousands of products to make them visually appealing. Red No. 3, used for decades, was finally banned by the FDA in January 2025 after the agency’s own data showed it causes cancer in animals.[2] It took until 2025.

High-fructose corn syrup, engineered to be sweeter and cheaper than sugar, metabolized by the liver differently than naturally occurring sugars, and linked to fatty liver disease, insulin resistance, and obesity.[3]

Emulsifiers like carrageenan and polysorbate 80, added to improve texture and shelf life, with emerging research suggesting they disrupt gut microbiome integrity and promote systemic inflammation.[4]

Artificial preservatives including BHA and BHT, added to prevent oxidation in packaged foods, classified as reasonably anticipated human carcinogens by the National Toxicology Program.[5]

Partially hydrogenated oils and industrial trans fats, so thoroughly documented as cardiovascular poison that the FDA banned them in 2018, but not before decades of consumption drove heart disease rates that still haven’t fully recovered.[6]

And over 1,000 other ingredients added to the food supply under the FDA’s “Generally Recognized As Safe” program, GRAS, in which food companies are permitted to certify the safety of their own ingredients without notifying the FDA or the public.[7] The MAHA Commission has specifically targeted this loophole for reform, and they are right to do so. An industry self-certifying its own ingredients as safe is not a regulatory system. It is an honor system operating inside a profit motive.

I agree with the core food agenda that Secretary Kennedy and the Make America Healthy Again movement have put on the national table: petroleum-based dyes should come out of the food supply, GRAS loopholes should be closed, ultra-processed food should be defined at the federal level, and SNAP benefits should not fund products with zero nutritional value. These are not partisan positions. They are basic public health positions backed by overwhelming evidence.

What It Is Doing to Your Body

The research on this is no longer at the frontier. It is settled, repeated, and alarming.

A 2024 umbrella review in The BMJ, covering 45 meta-analyses and nearly 10 million study participants, found convincing evidence that a diet high in ultra-processed foods increases the risk of death from cardiovascular disease by 50%.[8] Highly suggestive evidence placed the increased risk of obesity at 55%, Type 2 diabetes at 40%, and death from heart disease at 66%.[8]

The American Heart Association’s own 2025 Science Advisory confirmed that high versus low intake of ultra-processed foods is linked to a 25% to 58% higher risk of cardiometabolic outcomes and a 21% to 66% higher risk of mortality.[9]

Every additional 100 grams per day of ultra-processed food consumption is associated with a 14.5% higher risk of hypertension, a 5.9% increased risk of cardiovascular events, and a 19.5% higher risk of digestive diseases.[10]

These are not small signals. These are population-level findings, replicated across dozens of independent studies on tens of millions of people, in peer-reviewed journals at the highest level of evidence medicine produces.

The result, in real terms: more than 2 in 5 American adults now have obesity.[11] Treating diabetes and prediabetes costs this country over $327 billion annually.[12] Obesity-related medical care runs nearly $173 billion per year.[11] Ninety percent of all U.S. healthcare spending goes toward people with chronic and mental health conditions, most of them diet-related.[13]

The CDC projects that chronic disease will cost the United States $47 trillion between now and 2039.[14]

I’ll say that again. Forty-seven trillion dollars. Over the next 15 years. Driven in enormous part by conditions that trace directly to what is being sold at every grocery store, fast food counter, vending machine, and school cafeteria in America.

The Synthetic Dye Problem Is Bigger Than You Think

I want to spend a moment on food dyes specifically, because this is where the policy fight is most visible right now and where the industry’s behavior has been most egregious.

The synthetic dyes currently in the American food supply are petroleum derivatives. They are banned or heavily restricted in the United Kingdom, the European Union, Japan, and Australia, where products containing them must carry warning labels stating that the food “may have an adverse effect on activity and attention in children.”[15] In the U.S., they carry no warning. They are in children’s cereals, fruit snacks, sports drinks, candies, macaroni and cheese, and thousands of other products specifically marketed to children.

In 2025, roughly 75 bills targeting food dyes were introduced in 37 states.[16] West Virginia banned Red No. 40, Yellow No. 5, and Yellow No. 6 by law. California had already moved on four additives. Nestlé, Hershey, and PepsiCo pledged to begin removing synthetic colors voluntarily. The Consumer Brands Association asked its members to eliminate federally certified artificial dyes from products by end of 2027.[16]

The industry did not do this because they suddenly grew a conscience. They did it because the political pressure finally became unavoidable. These ingredients have been known to carry risk for decades. They stayed in the food supply because removing them cost money.

That calculation, what is profitable versus what is safe, is the operating logic of the entire ultra-processed food system. It has been from the beginning.

The Loop Nobody Talks About

Here is the part that should make you the most angry.

The food industry spends hundreds of millions of dollars every year lobbying against nutritional labeling requirements, sugar taxes, marketing restrictions to children, and front-of-pack warning labels.[17] They fund nutrition research designed to produce favorable conclusions. They helped shape decades of USDA dietary guidelines. They fought trans fat restrictions for years after the science was clear.

And when the chronic disease epidemic their products helped create shows up in your body, the hospital system is there to treat it. At $26,993 per year in employer-sponsored insurance premiums.[18] With a deductible that has gone up every year.[19] With an insurance company that will spend the next 90 days deciding whether your treatment is approved.

The food industry makes you sick. The healthcare industry charges you to manage it. Neither has a financial incentive for you to be well.

I am not speculating about this. I am describing the system as it functions, from inside it.

What I See in the Operating Room

I operate on patients whose joints have been destroyed in part by the inflammatory burden of decades of ultra-processed food consumption. I see the metabolic consequences, the effects of chronic systemic inflammation, the tissue changes that come from bodies running on ingredients they were never designed to process, every week.

These are not people who made bad choices. These are people who ate the food that was available, affordable, and relentlessly marketed to them by an industry that knew, and put the profit calculation ahead of the public health consequence.

I want fewer patients in my operating room, not more. The only path to that is a food supply that stops manufacturing the chronic disease that fills it.

What You Can Do Right Now

Read the ingredient label, not the nutrition facts panel. The nutrition facts panel is what the industry wants you to look at. Calories, fat grams, and protein are distractions. The ingredient list is where the truth is. If it contains synthetic dyes, HFCS, partially hydrogenated anything, or additives you cannot trace to a whole food source, that product is a bet against your long-term health.

Cook whole food when you can. Not as a lifestyle aspiration. As a defensive act. The data on what ultra-processed food does to your cardiovascular system, your metabolic health, and your mortality risk is overwhelming.

Support the food policy reforms that are actually grounded in evidence: mandatory front-of-pack warning labels, closure of the GRAS self-certification loophole, removal of petroleum-derived dyes from the food supply, and restrictions on ultra-processed food marketing to children. These are not radical positions. They are the standard in most of the developed world.

And when the food industry tells you their product is part of a balanced diet, ask who paid for that research.

Why I’m Writing This

I am inside the machine. I see both the food system’s consequences and the healthcare system’s response to them, up close, every week. Most people with the standing to speak about this from the inside have financial relationships that keep them quiet.

I don’t.

The Incision Point exists because the American public deserves a straight account of what is actually happening to their health, who is responsible, and what can actually change it. Not from a commentator. From a physician who is operating on the results.

Subscribe if you want to keep reading. Share this if it made you angry enough to want someone else to see it.

That anger is appropriate. Use it.

What ingredient on a food label has surprised or disturbed you most? Drop it in the comments.

Footnotes

1. CDC/NCHS Data Brief No. 536, August 2025. “Ultra-Processed Food Consumption Among U.S. Children and Adults, August 2021-August 2023.” cdc.gov

2. FDA, “FDA Revokes Authorization for the Use of Red No. 3 in Food and Ingested Drugs,” January 2025. fda.gov

3. Multiple sources including NIH research on fructose metabolism and fatty liver disease; Stanhope KL et al., multiple publications on high-fructose corn syrup and metabolic outcomes.

4. Chassaing B et al. “Dietary emulsifiers impact the mouse gut microbiota promoting colitis and metabolic syndrome.” Nature. 2015;519:92-96. Subsequent human studies have supported the association.

5. National Toxicology Program, U.S. Department of Health and Human Services. Report on Carcinogens listings for BHA and BHT.

6. FDA, “Final Determination Regarding Partially Hydrogenated Oils,” 2018. fda.gov

7. MAHA Commission Assessment, May 2025; ABC News reporting on GRAS reform proposals, September 2025.

8. Lane MM et al. “Ultra-processed food exposure and adverse health outcomes: umbrella review of epidemiological meta-analyses.” BMJ. 2024;384:e077310. doi:10.1136/bmj-2023-077310

9. American Heart Association Science Advisory, 2025. newsroom.heart.org

10. American College of Cardiology analysis of systematic review data, May 2025. acc.org

11. CDC, “Fast Facts: Health and Economic Costs of Chronic Conditions,” August 2025. cdc.gov

12. American Diabetes Association, cost of diabetes data, cited 2025.

13. CDC, “Health and Economic Costs of Chronic Diseases.” cdc.gov

14. Partnership to Fight Chronic Disease/GlobalData. December 2025. fightchronicdisease.org

15. European Food Safety Authority assessments of synthetic food dyes; UK Food Standards Agency labeling requirements.

16. KFF Health News, “RFK Jr.’s MAHA Movement Has Picked Up Steam in Statehouses,” January 13, 2026. kffhealthnews.org

17. Multiple lobbying expenditure analyses cited in Ballard Brief, BYU, “The Overconsumption of Ultra-Processed Foods in the United States,” 2024.

18. KFF 2025 Employer Health Benefits Survey, October 2025. doi:10.1377/hlthaff.2025.01106

19. KFF Health News, “A New Car vs. Health Insurance? Average Family Job-Based Coverage Hits $27K,” October 2025.

Editorial note on seed oils: The research on isolated seed oil consumption is genuinely contested, with the mainstream peer-reviewed consensus, including 2025 findings from Johns Hopkins, the American Heart Association, and multiple meta-analyses, finding that linoleic acid in seed oils is not the independent driver of inflammation or cardiovascular disease that MAHA messaging claims. The article frames seed oils as one industrially deployed ingredient within the broader ultra-processed food system, which is the scientifically defensible position.

I do not learn about my patients from their charts.

I learn about them from their tissue.

After 10,000+ joint replacements, I can tell within the first few minutes of a case what kind of physical life someone has been living. The quality of the muscle surrounding the joint. The integrity of the supporting structures. The biological age of the architecture I am working inside — which is often dramatically different from the number on the patient’s wristband.

Two patients last year. Similar age. Similar diagnosis. Similar preoperative pain scores. Completely different bodies on the table.

The first was strong. Not a competitive athlete — just someone who had lifted consistently for years, maintained their muscle mass, kept their posture upright and their supporting structures intact. The surgery was clean. Recovery was textbook. They were walking without assistance faster than the protocol predicted.

The second had spent a decade doing what most Americans do for fitness — some walking, occasional cardio, nothing that loaded the skeletal muscle with any real demand. The muscle surrounding the joint was atrophied and soft. The supporting architecture was compromised. The surgery was harder. Recovery was slower. The complications were not dramatic, but they were real, and they were predictable.

Same diagnosis. Same surgeon. Completely different outcomes.

The difference was muscle. And nobody had ever told the second patient that muscle was something they needed to deliberately build and protect.

That failure is not the patient’s fault. It is the system’s.

The Silent Epidemic Nobody Is Screening For

Sarcopenia — the progressive loss of skeletal muscle mass and function — is one of the most consequential and least discussed health crises in American medicine.

After age 30, the average adult loses between 3 and 8 percent of muscle mass per decade without deliberate intervention. After 60, that rate accelerates. By the time most people arrive at my operating table in their sixties and seventies, they have been losing muscle for three decades and have never once had a physician discuss it with them, screen for it, or prescribe anything to address it.

The downstream consequences are not limited to surgical outcomes. A 2022 meta-analysis published in the Journal of Cachexia, Sarcopenia and Muscle examining data from over 700,000 individuals found that low muscle mass is independently associated with all-cause mortality, cardiovascular mortality, and metabolic disease — with effect sizes comparable to established risk factors like hypertension and dyslipidemia.

Low muscle mass is as dangerous as high blood pressure. We screen aggressively for one. We do almost nothing about the other.

The annual physical does not measure muscle mass. It does not assess grip strength — one of the most validated predictors of long-term mortality in the literature. It does not ask about resistance training. It measures weight, which tells you almost nothing useful about the composition of that weight or the biological function of the body carrying it.

A scale weight is not a health metric. Muscle mass is.

The Cardio Lie We Have Been Living

I want to challenge something that has been accepted as health gospel for forty years.

The dominant fitness narrative in America — the one that produced a generation of recreational runners, spin class devotees, and elliptical machine regulars — is built almost entirely around cardiovascular exercise. Cardio for heart health. Cardio for weight loss. Cardio as the primary currency of physical fitness.

Cardiovascular exercise has real and documented benefits. I am not dismissing it.

But cardio does not build muscle. And muscle, it turns out, is not optional.

The cultural over-indexing on cardio has produced millions of metabolically fragile people who are aerobically functional but structurally deficient — people whose hearts are reasonably conditioned but whose skeletal muscle is insufficient to protect their joints, regulate their metabolism, or sustain them through a major medical event.

I see them on my table regularly. Thin, aerobically active, and sarcopenic. The combination is more common than most people realize, and it is more dangerous than simple obesity in certain surgical contexts because it carries none of the visible warning signs that trigger clinical concern.

The engineering problem here is straightforward: you cannot maintain a structure without loading it. A joint unsupported by adequate muscle is a joint under accelerated mechanical stress. A skeleton not subjected to regular resistance load loses density. A body that only moves through low-resistance, repetitive motion patterns develops the postural adaptations of exactly the lifestyle it is living.

Sitting is a structural problem as much as a metabolic one. The anterior pelvic tilt, the forward head posture, the shortened hip flexors and inhibited glutes that characterize a desk-bound population — these are not cosmetic issues. They are mechanical loading problems that alter joint stress patterns and accelerate the degenerative cascade I am eventually asked to surgically address.

The body adapts to the demands placed on it. If the demand is eight hours of sitting and thirty minutes of walking, the body optimizes for exactly that. It does not maintain architecture it is not being asked to use.

What Muscle Actually Does

Here is the piece the cardio-only conversation misses entirely.

Skeletal muscle is not simply a mechanical system for moving the body. It is an endocrine organ — one of the largest in the body — that produces and secretes signaling molecules called myokines in direct response to mechanical load.

Myokines regulate systemic inflammation, glucose metabolism, cognitive function, immune response, and fat oxidation. IL-6 released from contracting muscle during resistance exercise has potent anti-inflammatory effects — the same cytokine that drives pathology when chronically elevated by stress and poor diet becomes protective when acutely released through muscular contraction.

Irisin, a myokine released during resistance training, crosses the blood-brain barrier and has been associated in multiple studies with reduced neurodegeneration and improved cognitive function. BDNF — brain-derived neurotrophic factor — is upregulated by resistance exercise and represents one of the most powerful known stimulants of neuroplasticity.

When you lift, you are not just building muscle. You are running an anti-inflammatory protocol, a metabolic optimization program, and a cognitive enhancement intervention simultaneously.

There is no drug that does all of that. There is no supplement that replicates it. There is only load.

The Framework: Muscle First

I want to give you something concrete to carry out of this article.

1. Reframe the goal. The objective of exercise is not weight loss or cardiovascular fitness. Those are byproducts. The primary objective is building and maintaining skeletal muscle mass throughout your lifespan. Every other benefit follows from that.

2. Resistance training is non-negotiable. Two to three sessions per week of progressive resistance training — exercises that place genuine mechanical demand on major muscle groups — is the minimum effective dose. Not yoga. Not walking. Not the light resistance band routine. Load. Progressive, deliberate, increasing over time.

3. Protein supports the structure. Muscle protein synthesis requires adequate dietary protein. The RDA of 0.8g per kilogram of body weight was established to prevent deficiency, not to optimize muscle maintenance in aging adults. The sports medicine and longevity literature consistently supports 1.6 to 2.2g per kilogram for anyone over 40 who is training with intent.

4. Posture is structural integrity. If you sit for more than six hours a day, your hip flexors are shortened, your glutes are inhibited, and your spine is loaded in a pattern it was not designed to sustain indefinitely. Address this deliberately — not with stretching alone, but with the resistance training that restores the posterior chain function that sitting systematically dismantles.

5. Start now, not later. The research on resistance training benefits in adults over 60, 70, and even 80 is unambiguous — it is never too late to build meaningful muscle and recover meaningful function. But the earlier you start, the more you are protecting rather than rebuilding.

The Prescription We Are Not Writing

I am a surgeon. I fix joints that have failed. I am good at it, and I will keep doing it.

But the most important intervention I can offer most of my patients is not the surgery. It is the conversation I try to have before surgery becomes necessary — the one about what their body needs to stay out of my operating room.

Muscle is medicine. It is the most powerful preventive intervention available for joint disease, metabolic disease, cognitive decline, and all-cause mortality. It is free, it is accessible, and it requires no prescription.

We are not prescribing it. We are not screening for its absence. We are not teaching it in medical school with anything close to the emphasis the evidence demands.

That needs to change. And it starts with surgeons — who see the consequences more clearly than almost anyone — leading that conversation rather than waiting for the system to have it.

Build the muscle. Protect the structure. Do not wait until someone like me is the next appointment on your calendar.

That is the incision point.

Are you lifting? Or are you still in the cardio trap?

Tell me where you are… and what is stopping you from changing it.

Dr. Michael Meneghini

I have looked inside more than 10,000 human joints.

I can tell you things about the human body that do not show up in textbooks. I can tell you what a life of chronic stress looks like in synovial tissue. I can tell you the difference between a joint that has been quietly inflamed for a decade and one that has not.

What I see more than anything else, in patient after patient, year after year, is the same thing.

Inflammation. Systemic, chronic, low-grade, and almost entirely invisible until it is not.

The frustrating part is not that this is happening. The frustrating part is that we have the tools to detect it early, the knowledge to address it directly, and a medical system that has organized itself almost perfectly to do neither.

I know this because I almost missed it in myself.

The Silent Driver Nobody Is Naming

Chronic low-grade inflammation is the common upstream driver of the four leading causes of death in America — cardiovascular disease, cancer, diabetes, and Alzheimer’s disease.

Not a contributing factor. The upstream driver.

A landmark analysis published in Nature Medicine in 2023 examined data from nearly 45 million patients and concluded that chronic inflammation is implicated in more than 50% of all deaths globally. The inflammatory cytokine interleukin-6, elevated C-reactive protein, and chronic activation of the NF-kB signaling pathway appear across the pathology of heart disease, type 2 diabetes, multiple cancers, and neurodegenerative disease with a consistency that is no longer scientifically debatable.

We are not talking about the acute inflammation that heals a wound. That version is one of the most elegant systems in biology. We are talking about its chronic, dysregulated cousin — the kind that never fully switches off, that quietly degrades tissue over years and decades, that shows up in your bloodwork as a whisper long before it announces itself as a diagnosis.

Your annual physical is almost certainly not testing for it.

What the OR Taught Me

I started noticing a pattern years into my surgical career.

Two patients, similar age, similar weight, similar preoperative function scores. I open the first joint and the tissue is relatively healthy. I open the second and it is a different story entirely — inflamed synovium, degraded tissue quality, a joint that looks biologically a decade older than the chart suggests.

The difference was not always explainable by diagnosis alone. It was systemic.

I started asking more questions. Diet. Sleep. Stress. Movement. The answers were predictable in their consistency. Then I ran my own labs — and found markers I did not expect in someone performing, by every external measure, at a high level.

That was the moment I understood this personally, not just clinically.

The association between systemic inflammation and poor surgical outcomes is well-documented. Elevated preoperative CRP is an independent predictor of complications after joint replacement. Metabolic syndrome substantially increases infection risk, wound complication rates, and implant failure. I was seeing the end stage of a process that had started silently, years earlier, that nobody had ever named for these patients.

The System Is Built to Miss It

We are organized to treat disease, not to prevent it. And chronic inflammation sits in the gap between the two.

Your annual physical screens for acute illness and manages established diagnoses. It is a liability screen dressed up as a health assessment — almost entirely backward-looking. It identifies what has already gone wrong, not what is quietly accumulating.

High-sensitivity CRP — the most accessible and clinically validated marker of systemic inflammation — is not standard on most wellness panels. It costs a few dollars to run. The JUPITER trial, published in the New England Journal of Medicine in 2008, enrolled nearly 18,000 patients with normal LDL but elevated hsCRP and demonstrated that treating the inflammatory burden reduced cardiovascular events significantly.

That was 2008. Seventeen years ago. hsCRP is still not standard of care.

The system is not failing by accident. Prevention does not bill. Chronic disease management does. That is not cynicism. That is an incentive structure.

And then there is the NSAID problem.

Americans consume approximately 30 billion doses of NSAIDs annually. They are the default response to the pain and stiffness that chronic inflammation produces. They do not address inflammation. They suppress its signal.

Long-term NSAID use carries documented risks. A 2017 meta-analysis in the British Medical Journal examining more than 446,000 patients found that all common NSAIDs were associated with significantly elevated risk of acute myocardial infarction — with risk emerging within the first week of use.

We are managing the signal of chronic inflammation with a drug class that, at population scale, is generating its own cardiovascular burden. This is what symptom suppression without root cause resolution looks like in practice.

Two Things You Can Do This Week

Ask for hsCRP on your next blood panel.

It is inexpensive, widely available, and requires no special preparation. Optimal is below 1.0 mg/L. Above 2.0 mg/L represents elevated cardiovascular risk. Above 3.0 mg/L is high risk. If you are above 2.0 and nobody has discussed it with you, you are in the gap the system is not designed to address. While you are at it, ask for homocysteine — independently associated with cardiovascular disease, cognitive decline, and systemic inflammatory burden. Both tests together cost less than a co-pay.

Remove the fuel.

Chronic inflammation has inputs. The most powerful modifiable ones, ranked by the strength of the evidence: diet first — ultra-processed food, refined seed oils, and added sugar directly drive the NF-kB inflammatory pathway. Sleep second — a single night of poor sleep measurably elevates IL-6 and TNF-alpha. Movement third — resistance training specifically produces anti-inflammatory myokines through skeletal muscle; a sedentary body is an inflamed body. Chronic stress fourth — sustained cortisol elevation drives inflammatory gene expression, documented in the psychoneuroimmunology literature for thirty years.

None of these require a prescription. None generate revenue for the sick-care system. All of them work.

Treat the Root, Not the Branch

Every chronic disease conversation you will have with a doctor is a branch conversation. Statins for cholesterol. Metformin for blood sugar. NSAIDs for joint pain. Clinically appropriate in many contexts. Entirely silent on the root.

The root is inflammation.

The branch conversations are not wrong. They are incomplete. And incomplete, at population scale, over decades, is how you end up with a country where chronic disease is the norm and the healthcare system calls it inevitable aging.

It is not inevitable. Ask for the test. Change the inputs. Have the root conversation.

That is the incision point.

What markers is your doctor running? AND, what’s missing from your panel?

Tell me below.

Dr. Michael Meneghini

My patients are always asking me where their money goes.

Not about their diagnosis. Not about recovery time. The first question, more often than I’d like to admit, is some version of: “Doctor, what is this going to cost me?”

These are working people. People with jobs, with insurance cards in their wallets, with coverage they’ve paid into for years. And they are terrified of the bill that comes after I help them.

That fear is not irrational. That fear is the correct response to a system that has been taking their money for decades and delivering less every year in return. I’ve watched it happen from inside the operating room, inside the boardroom, and inside the data. And I’m done staying quiet about it.

The Number They Don’t Put on the Benefits Brochure

The average American family with employer-sponsored health insurance is now paying $26,993 per year in premiums.[1] Just premiums. Before you’ve seen a single doctor. Before you’ve filled a single prescription.

Your employer pays the bigger share of that. But your portion comes out of your paycheck every two weeks, quietly, before you ever see it. And then, when you actually need care, you pay again. Deductibles. Copays. Coinsurance. Out-of-network surprise bills that arrive two months after a procedure you thought was covered.

Add it all up: a family of four with “good” employer insurance is carrying nearly $29,000 in total annual healthcare costs.[2]

More than most Americans spend on housing.

And it has gone up 6% or more, every single year, for three years running.[3] Not because the care is getting better. Not because the outcomes are improving. Because the entities that control your access to care have spent decades making sure there is nowhere else to go.

Here Is What Is Actually Happening to Your Money

I need you to understand this part clearly, because the people profiting from your confusion are counting on it staying confusing.

When you go to a hospital for a procedure, you are not just paying your surgeon. You are paying a facility fee. That fee goes to the hospital itself. And because hospital systems have spent the last 20 years buying up every competing practice, clinic, and surgery center in their market, there is increasingly nowhere else to go.

In 2023, one or two hospital systems controlled all commercial inpatient care in roughly half of all U.S. metropolitan areas.[4] Half the country. One or two choices. When competition disappears, prices go one direction.

Your insurer is not fighting this on your behalf. They negotiated contracts with those same hospital systems years ago. The terms are confidential. The prices are hidden. And when costs rise faster than they can absorb, their move is not to push back on the hospital. Their move is to raise your deductible, narrow your network, and deny more of your claims.

None of that reduces what the hospital charges. It just moves more of the bill directly onto you.

This is not an accident. It is not incompetence. It is a business model running exactly as designed.

The Doctor in That Room Isn’t Getting Rich Either

I want to say something that surprises most people.

Physician compensation, adjusted for inflation, has declined significantly over the past two decades, even as premiums have exploded.[5] The average doctor today spends nearly as much time on insurance paperwork and prior authorization battles as on patient care.[6]

Burnout among American physicians is approaching 50%. Not because doctors stopped caring. Because the system converted them into billing units inside someone else’s revenue machine.

I’ve been that doctor. I trained at Mayo Clinic. I have an engineering degree from Rose-Hulman. I have performed more than 10,000 joint replacements. And I have sat in boardrooms in my scrubs listening to hospital executives discuss “margin optimization” while my patients asked me what their surgery was going to cost them.

At a certain point, you stop rearranging the chairs.

I left. I built Indiana Orthopedic Institute from two people to more than 100 employees and 16 surgeons in three years, physician-owned, patient-first, transparent on cost. Not because I had a brilliant business idea. Because patients and employers found us, saw what care could actually look like, and refused to go back to the alternative.

That tells you everything about how hungry people are for something different.

The Lower-Cost Option Exists. You Just Don’t Know About It.

This is the part that makes me the most frustrated. Because the solution isn’t theoretical. It is operating right now, in thousands of locations across the country, and most patients have no idea.

Ambulatory surgery centers, or ASCs, are physician-owned outpatient surgical facilities. For most elective procedures, including the joint replacements I perform every week, the clinical outcomes are equivalent to hospital-based care.

The cost is not.

The same procedure in an ASC costs less than half of what it costs in a hospital outpatient department.[7] Medicare alone saves an estimated $4.2 billion every year by routing surgeries to ASCs instead of hospitals.[7] Patients save an average of $684 per procedure, out of pocket, just by changing the location of their care.

Some employers have figured this out. They are now contracting directly with physician-owned surgery centers, sending their employees in for procedures, waiving all out-of-pocket costs, and still coming out ahead financially compared to what their insurance network would have charged at the local hospital.[8]

The employer pays for the flight. Pays for the hotel. Covers every dollar of the procedure. And still saves money.

That gap between what the hospital charges and what a physician-owned facility charges is not a small inefficiency. It is the size of the lie the system has been telling you.

Why I’m Writing This

I am a surgeon. I fix broken things.

The American healthcare system is broken in ways that are specific, documented, and solvable. And the people most harmed by it, the families watching their paychecks erode, the patients who delay care because they cannot predict the bill, the workers who technically have insurance and still end up in medical debt, are also the people who have been given the least access to a straight explanation of what is actually happening.

That is what I’m here to change.

I am not a policy analyst. I am not a commentator watching this from a distance. I am inside the machine, every single week, seeing the consequences of these decisions in the people who come to me in pain and leave scared about the bill. That proximity gives me something most healthcare writers don’t have: I know exactly where the bodies are buried, and I have nothing to lose by saying so.

If you want the unfiltered version of what is actually happening in American healthcare, subscribe. Every piece I write is grounded in clinical data, operational experience, and the kind of specificity you don’t get from people who have never stood at an operating table or walked out of a hospital boardroom furious.

If this article made you angry, share it. The system counts on your frustration staying private. Make it loud.

And if you have a healthcare bill sitting on your kitchen table right now that you don’t understand, drop a comment below. I read every one. You deserve a straight answer.

Thanks for reading.

Dr. Michael Meneghini

What is the most absurd medical bill you’ve ever received? I want to know.

Footnotes

1. KFF 2025 Employer Health Benefits Survey, October 22, 2025. Wager E et al. Health Benefits in 2025: Family Premiums Rise 6 Percent. Health Affairs. doi:10.1377/hlthaff.2025.01106

2. Peterson-KFF Health System Tracker, “How Much Do People with Employer Plans Spend Out-of-Pocket on Cost-Sharing?” February 2026. healthsystemtracker.org. Note: total figure based on 2024 premium and out-of-pocket data; 2025 total will be higher given the 6% premium increase.

3. KFF Health News, “A New Car vs. Health Insurance? Average Family Job-Based Coverage Hits $27K,” October 28, 2025. kffhealthnews.org

4. Peterson-KFF Health System Tracker, “Eight Trends Shaping 2026 Healthcare Costs,” March 2026. healthsystemtracker.org

5. Physician compensation trend data. Note: the directional decline is well-documented across multiple sources including Merritt Hawkins and the Physician Advocacy Institute. Recommend substituting a personal data point or a specific sourced figure before final publication.

6. Arndt BG et al. “Tethered to the EHR: Primary Care Physician Workload Assessment Using EHR Event Log Data and Time-Motion Observations.” Annals of Family Medicine, 2017. Directionally consistent with more recent analyses; recommend updating citation if a more recent source is available.

7. Ambulatory Surgery Center Association (ASCA)/KNG Health Consulting, Medicare cost savings analysis; Colliers Q3 2025 Healthcare Services Report, via Healthcare Finance News, October 2025.

8. ASC News, “Top Ambulatory Surgery Center Trends for 2025,” January 2025, citing Surgery Center of Oklahoma. ascnews.com

Healthcare is now an $11 trillion global industry.

That number is projected to reach $21 trillion by 2030 - a compound annual growth rate (CAGR) of roughly 7%.

Let me put that in perspective. That is a similar growth rate to semiconductor chips and Apple Inc.. Healthcare is growing faster than most technology sectors, and we are not curing anything or inventing something new. We are managing disease. We are keeping people alive, sick, and returning - year after year - to a system that profits from their continued illness.

That is not healthcare. That is the healthcare industry. And there is a profound difference.

We Are Not Curing Anything

The two primary drivers of this explosive growth are an aging population and the rising prevalence of chronic disease.

Diabetes. Obesity. Cardiovascular disease. Osteoarthritis. Conditions that, in many cases, are directly traceable to lifestyle - to processed food, physical inactivity, poor sleep, and chronic stress. These are not mysteries. The science is settled.

The global population aged 65 and older is projected to reach 1.5 billion in the coming decades, and healthcare spending on this age group alone is expected to exceed $1.2 trillion.¹ That is a staggering number. But here is the question no one in the healthcare industry wants to answer honestly: how much of that spending is curative versus palliative?

Very little of it is curative.

We are not winning the war on chronic disease. We are funding its perpetual management. The pharmaceutical companies are not incentivized to cure diabetes - they are incentivized to sell insulin, GLP-1 agonists, and metformin for the next 50 years. The hospital systems are not incentivized to keep patients away - they are incentivized to fill beds, generate readmissions, and maximize billing codes.

The business model of American healthcare is predicated on sick people staying sick.

I do not say that as a conspiracy theory. I say it as someone who has operated inside this machine for 20+ years.

The Trillion-Dollar Waste Machine

Here is what the system will not advertise: a landmark study published in JAMA estimated the annual cost of waste in the US healthcare system at between $760 billion and $935 billion - approximately 25% of total healthcare spending.²

A quarter of everything we spend. Gone.

Where does it go? Let me count some of the ways:

1. Administrative complexity - the largest single category of waste, estimated at $266 billion annually. The average physician spends the equivalent of $68,000 per year dealing with billing-related activities.³

2. Overtreatment and low-value care - procedures that deliver no clinical benefit, costing between $75 billion and $101 billion per year.²

3. Pricing failure - inflated rates for medications, payer-based services, and laboratory work, totaling $230 billion to $240 billion annually.²

4. Failure of care coordination - patients discharged without follow-up, readmitted unnecessarily, bounced between specialists who never communicate.

5. Fraud and abuse - upcoding, phantom billing, charges for services never rendered.

6. Unnecessary inpatient stays - keeping patients in hospital beds for days when the procedure required hours.

7. $4 billion hospital campuses - monuments to institutional ego that embed overhead costs into every single patient encounter.

8. Redundant diagnostic testing - the same MRI ordered by three different departments because no one shares records.

9. Prior authorization bureaucracy - clinical decisions made by insurance adjusters, not physicians, delaying care and consuming physician time.

10. Hospital-employed physician models - where a physician’s productivity is taxed at 40% to 60% by the health system overhead above them.

11. Pharmaceutical rebate games - where list prices bear no relationship to actual costs, and the spread disappears into the supply chain.

12. Defensive medicine - tests ordered to protect against litigation, not to treat the patient.

13. Supply chain opacity - hospitals paying 3x markup on devices because they lack price transparency.

14. Chronic disease management without root-cause treatment - managing downstream consequences rather than addressing lifestyle upstream.

15. EHR systems built for billing, not for care - physicians spending 2 hours on documentation for every 1 hour of patient interaction.

16. Credentialing and compliance bureaucracy - armies of administrators generating paperwork that does not improve a single patient outcome.

17. Preventable readmissions - failures of care delivery costing $102 billion to $165 billion per year,² much of it traceable to inadequate discharge planning.

18. Drug waste - hospitals discarding an estimated $3 billion in unused medications annually.

19. Executive compensation at nonprofit hospital systems - C-suite salaries that would embarrass a hedge fund, justified by “mission-driven” language.

20. The construction of $1 billion-plus inpatient facilities for elective procedures that belong in outpatient settings.

The US spends over $1,000 per capita on administrative costs alone - more than three times the OECD average of $194.⁴ Germany, our closest peer, spends $306. We spend $1,055.

The delta is not care. The delta is overhead, complexity, and institutional self-preservation.

The $4 Billion Hospital Problem

Let me address this directly, because no one in healthcare leadership will.

Henry Ford Health recently announced plans to build a new $1.8 billion hospital at its main campus in Detroit,⁵ part of a broader $2.5 billion development. They are not alone. Across the country, health systems are building flagship campuses that cost more than NFL stadiums, financed on the backs of insurance reimbursements and, ultimately, the patients and employers paying those premiums.

National average hospital construction costs have increased more than 20% over the past five years.⁶ These are not investments in better outcomes. They are investments in market share, in signaling institutional dominance, in capturing more inpatient volume for procedures that don’t require inpatient stays.

A hospital should be for life-threatening situations. Trauma. Complex cardiac surgery. Stroke. Oncology. That is what the inpatient environment is built for.

It is not built for a knee replacement. It is not built for a hip. Not for a rotator cuff. Not for a spine decompression. Not for the hundreds of elective procedures that require 90 minutes in an operating room and a few hours of recovery.

Yet patients are admitted, kept for 3 to 5 days, and billed at rates that would make the hotel industry blush - because the system is designed to maximize inpatient revenue, not to serve the patient.

530,000 Families a Year

While the health systems build billion-dollar campuses, the patients are going bankrupt.

Every year, approximately 530,000 American families file for bankruptcy due to medical bills.⁷ Medical debt is the leading cause of personal bankruptcy in the United States - a phenomenon that is virtually nonexistent in every other developed country in the world.

Almost one in five adults with healthcare debt either lose their homes or declare bankruptcy.⁸

Think about that. Not in a developing country. Here. In the wealthiest nation in human history, people are losing their homes because they had a surgery.

This is not a healthcare system. This is an extraction machine wearing a white coat.

The Blueprint Already Exists: The ASC Model

I am not here to complain. I am here to offer the proof-of-concept that the system can be redesigned.

At Indiana Orthopedic Institute, we built our model around a core operational truth: the right care, delivered in the right setting, at the right time, costs significantly less and produces better outcomes. Our ambulatory surgery center is not a compromise. It is the standard.

The data is not ambiguous. Outpatient joint replacements performed in an ASC cost 40% less than those performed in a hospital. Rotator cuff repair and knee arthroscopy cost over 50% less.⁹

A study presented at the 2024 AAOS Annual Meeting found that procedures performed at ASCs resulted in approximately 35% savings in total cost, 41% savings on facility fees, and 36% savings in Medicare payments¹⁰ - across the board, not as an outlier.

On average, the Medicare program and its beneficiaries share in more than $2.3 billion in savings each year when patients receive surgical procedures at ASCs instead of hospital outpatient departments.¹¹

The ASC model is not an experiment. It is a proven, scalable alternative to inpatient care for elective procedures - with lower infection rates, shorter recovery times, higher patient satisfaction, and dramatically reduced cost.

Why keep a patient in the hospital for 4 days for a procedure that takes 2 hours?

There is one honest answer: money. The hospital charges more. The system is built to capture that revenue. And as long as the incentives are aligned toward inpatient volume, that is where the cases will go - regardless of what is actually best for the patient.

That alignment has to end.

The Operational Directive

If you are a surgeon reading this, here is what you need to understand: the hospital will not fix this. The insurance industry will not fix this. The federal government, which has been debating healthcare reform for 40 years, will not fix this on any timeline that matters to your patients today.

You have to build the alternative yourself.

That means owning your surgical setting. It means vertically integrating your practice around patient-centered, outcomes-focused, cost-transparent care. It means refusing to be a revenue generator for a corporate system that sees your clinical autonomy as a liability.

The preventive side of this equation matters equally. We will not bend the $21 trillion curve by building more hospitals. We will bend it by addressing root causes - sleep, nutrition, exercise, metabolic health. Those conversations need to happen in every clinic, every pre-op appointment, every post-op visit. Not as an afterthought. As the core clinical mission.

I built Indiana Orthopedic Institute from two people to 100 employees and $40M in three years. Not by following the corporate playbook. By rejecting it. By building something that actually works for the patient and, by extension, for everyone who touches the system.

The $21 trillion future is not inevitable. It is a choice.

Choose differently.

What systemic waste makes you the most angry - and what are you doing about it? Let’s hear it.

- Dr. Michael Meneghini

Sources

1. Ken Research, Global Healthcare Market Outlook to 2030 (2025)

2. Shrank WH, Rogstad TL, Parekh N. “Waste in the US Health Care System: Estimated Costs and Potential for Savings.” JAMA. 2019;322(15):1501-1509.

3. Peter G. Peterson Foundation. “Almost 25% of Healthcare Spending Is Considered Wasteful.” September 2025.

4. DocBuddy. “5 Statistics on Wasteful Health Spending.” Citing OECD comparative administrative cost data, 2021.

5. Commins J. “Hospital construction slows amid rising material costs.” Modern Healthcare. May 2023.

6. Giffin S. “Hospital construction costs increase.” Health Facilities Management Magazine. January 2024.

7. Balancing Everything. “Medical Bankruptcies Statistics.” Citing American Journal of Public Health and Consumer Bankruptcy Project data. February 2024.

8. RetireGuide. “49+ U.S. Medical Bankruptcy Statistics for 2023.” March 2025.

9. OSSM Newark. “Ambulatory Surgery Centers vs. Hospital Outpatient Departments.” Citing Orthopedics Review and multiple comparative studies. October 2024.

10. Smith S, et al. “Hand and Upper Extremity Procedures Are Significantly More Cost Effective when Performed in Ambulatory Surgery Centers versus Hospital Outpatient Departments.” Presented at AAOS Annual Meeting. March 2024.

11. Advancing Surgical Care / ASC Association. “The ASC Cost Differential.” Citing University of California Berkeley Center on Health Care Markets and Consumer Welfare data.

Cereal for breakfast. Chips and a sandwich for lunch. Whatever came out of a box or a bag at dinner when the schedule was too full to think about food. I was a competitive athlete. I was thin. I told myself the food was fine because my body looked fine.

It was not fine. I just could not see the damage yet.

The wake-up came gradually, then all at once - the way most important realizations do. I started tracking my own labs. I started reading the metabolic research, not the headlines. And I started connecting what I was seeing on my operating table to what my patients had been eating for decades. The inflammation. The tissue quality. The joint architecture of people in their fifties who looked, from the inside, like they were decades older.

Food did that. Specifically, the industrially engineered, deliberately addictive, government-subsidized products that the food industry has spent fifty years pretending are food.

I changed what I ate. My labs changed. My energy changed. My surgical performance changed.

And I got angry. Because none of this was accidental.

This Was Engineered - and We Have the Documents to Prove It

On April 8, 1999, eleven CEOs of America’s largest food companies - Kraft, Nabisco, General Mills, Procter & Gamble, Coca-Cola, Mars, and others - gathered secretly at Pillsbury headquarters in Minneapolis. There were no reporters. No minutes taken. No recordings made.

Kraft Vice President Michael Mudd took the stage and delivered a 114-slide presentation. His message: the industry’s products were driving the obesity epidemic, the science was clear, and collective action was the only path that would not end in congressional hearings and class-action litigation. He pleaded with the room. He named the stakes. He laid the evidence at their feet.

The CEO of General Mills stood up, pushed back, and the meeting ended without a single meaningful commitment.

This is not rumor. It is documented in Salt Sugar Fat by Pulitzer Prize-winning journalist Michael Moss - sourced from internal records and firsthand interviews with people in that room.

What followed was decades of investment in what the food industry calls “the bliss point” - the precise combination of sugar, salt, fat, and texture engineering that maximizes consumption and overrides the brain’s natural satiety signals.

Frito-Lay hired neuroscientists. Coca-Cola funded research designed to confuse the public about sugar’s role in obesity. General Mills engineers spent years calibrating the melt-in-your-mouth disintegration rate of Cheetos, because a snack that dissolves quickly registers fewer calories to the brain and keeps the consumption loop open.

This is not conspiracy theory. This is documented corporate strategy, confirmed in internal memos, depositions, and investigative reporting.

It is the tobacco playbook. Beat for beat.

Philip Morris - which owned Kraft for two decades - used the same internal research architecture to understand addiction and the same public relations machinery to deny it. The scientists who helped design nicotine delivery optimization in cigarettes were later consulting on flavor enhancement for processed foods. The connection is not metaphorical. It is organizational and personnel-level.

Tobacco killed people slowly and publicly, and it took fifty years and congressional testimony to hold it accountable.

Ultra-processed food is doing the same thing. At larger scale. With a better lobbying operation.

What “Ultra-Processed” Actually Means - and Why the Label Matters

The NOVA classification system, developed by researchers at the University of Sao Paulo, defines ultra-processed food not by individual nutrients but by industrial formulation: products that contain ingredients you would not find in a home kitchen - emulsifiers, flavor modulators, colorants, humectants, texturizers - assembled to maximize palatability, shelf life, and consumption rate.

We are not talking about bread or cheese. We are talking about products engineered in laboratories to behave differently in your brain than whole food does.

The research on what these products do is no longer preliminary. A landmark 2019 randomized controlled trial published in Cell Metabolism - led by Kevin Hall at the NIH - was the first to demonstrate causally, in a controlled setting, that ultra-processed food drives overconsumption. Participants eating ultra-processed diets consumed an average of 508 additional calories per day compared to matched whole-food diets, despite being given unrestricted access to both. They ate faster. They gained an average of 0.9 kg over just two weeks. The effect was not explained by differences in sugar, fat, sodium, or fiber content alone - it was something about the industrial formulation itself.

508 calories per day. Unintentionally. In a controlled research setting where the diets were matched calorie-for-calorie on paper.

That is not weak willpower. That is a neurologically targeted product working exactly as designed.

The addiction science has moved even further. Ultra-processed foods activate the same dopaminergic reward pathways as addictive substances. A 2023 review published in the British Medical Journal - synthesizing evidence across 281 studies from 36 countries - concluded that ultra-processed food addiction affects approximately 14% of adults and 12% of children globally, meeting formal DSM-5 diagnostic criteria for substance use disorder. Not metaphorical addiction. Clinical addiction, by psychiatric definition.

Fourteen percent of the adult population addicted to a product that is legally sold in every school, every hospital, every airport, and every gas station in America. And subsidized by the federal government.

What I See in the Operating Room

I want to make this concrete, because the population-level statistics can feel abstract until you are standing inside a patient.

Joint replacement surgery gives you an unusually direct view of what a lifetime of systemic inflammation does to human tissue. I have performed over 10,000 joint replacements. I can tell you that the difference between a patient who has spent decades eating a whole-food diet and one who has spent decades on ultra-processed food is visible - not just in their weight or their comorbidity list, but in the tissue itself.

Tissue quality is worse. Healing is slower. The inflammatory burden these patients carry into surgery elevates their complication risk before I make the first incision. Post-operative infection rates are higher in patients with metabolic syndrome driven by diet. Readmission rates are higher. Recovery timelines are longer.

I am not describing outliers. I am describing a pattern that any surgeon who operates at volume has seen repeatedly and that the outcomes data confirms.

The American Joint Replacement Registry data and multiple institutional studies have documented the association between obesity, metabolic syndrome, and worse surgical outcomes in joint replacement. The complication odds are not marginal. Obesity class II and III patients carry substantially elevated risks of periprosthetic joint infection, wound complications, and aseptic loosening.

Ultra-processed food is a primary driver of the metabolic syndrome that creates those patients.

The food industry created the problem. The healthcare system - including surgeons like me - spends billions managing the downstream consequences. And nobody in the chain is connecting those two facts in any policy that changes the upstream behavior.

The Government Is Funding Both Sides of This War

Here is the part that should make you genuinely angry.

Since 1995, corn subsidies alone have exceeded $116 billion - the same crop that gives us high-fructose corn syrup. In 2024 alone, Congress authorized more than $40 billion in combined commodity and disaster payments, the majority flowing to corn, soy, and wheat - the raw inputs for the ultra-processed food supply. High-fructose corn syrup, refined seed oils, processed soy derivatives: these are not cheap because they are efficient. They are cheap because American taxpayers subsidize the crops that make them.

At the same time, Medicare and Medicaid spend hundreds of billions annually managing the chronic disease load - diabetes, cardiovascular disease, obesity-related joint deterioration - that ultra-processed food consumption drives.

We are paying to make the poison cheap and then paying again to treat the poisoning.

According to a 2024 peer-reviewed analysis published in The Milbank Quarterly - drawing on 23 years of OpenSecrets data - the ultra-processed food industry spent $1.15 billion on federal lobbying between 1998 and 2020. More than Big Tobacco. More than alcohol. More than gambling.

That money successfully blocked meaningful front-of-package warning labels, fought sugar taxes in every major legislative context, and funded a generation of nutrition research designed to shift blame from processed food to individual behavior.

Sound familiar? It should. The tobacco industry wrote that playbook first.

What Actually Changes This

I changed my own diet because I read the research and I looked at my own labs and I made a decision that I was not willing to accept the standard American metabolic trajectory as inevitable.

That required no superhuman feat of willpower. It required removing the engineered food from my environment and replacing it with food that does not hijack the satiety system. Within weeks, the appetite patterns changed. The cravings that felt biological were, in fact, largely manufactured - and they diminished when the manufacturing stopped.

That is the most important practical truth in this entire conversation: this is not primarily a willpower problem. It is an environment problem. And you can change your environment.

But I also want to be clear about something. Individual action is necessary. It is not sufficient.

The same logic that says “smokers should just choose not to smoke” was used for fifty years to deflect from tobacco accountability. Personal responsibility matters. It does not absolve the companies who deliberately engineered the addiction, the lobbyists who blocked the regulation, or the politicians who took the money and protected the system.

Both things are true. You have to change what you eat. And the industry that spent fifty years engineering your overconsumption should face the same reckoning the tobacco industry eventually faced.

We are not there yet. But the science is no longer on their side.

The breakfast cereal in the brightly colored box. The chips engineered to dissolve before your brain counts the calories. The “low fat” products loaded with sugar to compensate for the removed fat. The snacks formulated by the same corporate lineage that spent decades optimizing nicotine delivery.

None of this was designed to feed you.

It was designed to keep you consuming. And it worked exactly as intended.

You can opt out. Start there.

And then get angry about the system that made opting in the default.

That is the incision point.

What changed things for you? Was it your labs? A health event?

Or are you still in the middle of figuring it out?

Tell me below. Would love to have a conversation.

- Dr. Michael Meneghini

The most prescribed drug in America right now has less than three years of long-term outcome data.

Nobody is saying that out loud.

GLP-1 receptor agonists - semaglutide, tirzepatide, the entire class - have taken over the cultural conversation about weight loss with a speed that should make every clinician uncomfortable.

Ozempic is a household name. Wegovy is on the cover of magazines. Celebrities are not-so-quietly crediting it. The stock prices have reflected a gold rush. And somewhere in the middle of all that noise, the actual science - careful, longitudinal, outcomes-based science - is still catching up.

I am not here to tell you GLP-1s are dangerous. The data does not support that.

I’m also not here to tell you to go out and get some either. The data also does not support that.

I am here to tell you we do not know enough yet. And in medicine, that distinction matters enormously.

The Rush to Prescribe Is Outrunning the Research

Here is what we actually know.

GLP-1 receptor agonists work. In the SURMOUNT-1 trial, tirzepatide produced mean weight reduction of approximately 22.5% at 72 weeks. The STEP 1 trial for semaglutide showed roughly 14.9% body weight reduction over 68 weeks.

Those are real numbers. Clinically meaningful. For patients with obesity-related comorbidities - cardiovascular disease, type 2 diabetes, joint deterioration - this class of drug has genuine, evidence-backed utility.

But here is what the headlines are not telling you.

The longest continuous outcome data we have on semaglutide for weight management is roughly two to three years. For a drug now being prescribed to millions of people as a long-term or potentially indefinite intervention, that is not a track record. That is a promising early chapter.

We do not yet know what happens to metabolic function at year five. Year ten. We do not know what the cessation curve looks like for patients who use these drugs for a decade and then stop. We are moving at cultural speed when the science demands clinical patience.

What Rapid Weight Loss Is Actually Doing to the Body

This is where I want to slow the conversation down considerably.

When a patient loses 15 to 22 percent of their body weight in 68 to 72 weeks, they are not losing fat alone. They are losing muscle. They are losing bone density. That is not a side effect. That is physiology.

The data on lean mass loss during GLP-1 therapy is real and it is underreported in the popular press. Studies tracking body composition during semaglutide treatment have shown that a significant portion of total weight lost - estimates range from 25 to 40 percent depending on the study and protocol - is lean mass, not adipose tissue. For a 50-year-old patient who is already dealing with age-related sarcopenia, that is not a neutral trade.

I operate on joints. I see what sarcopenic bodies look like - not on a DEXA scan but on an operating table. Weak, atrophied muscle around a joint is not just an aesthetic issue. It is a functional one, a structural one, and a surgical risk factor. Patients with low lean mass have worse outcomes after joint replacement. They recover more slowly. They fall more. The downstream consequences of aggressive muscle loss are not hypothetical to me.

Bone density tells a similar story. Rapid weight loss - regardless of mechanism - is associated with reductions in bone mineral density. We know this from bariatric surgery literature going back decades. GLP-1-driven weight loss may be less aggressive than surgical intervention, but the mechanism is not entirely different. The STEP trials were not powered to detect fracture risk as a primary endpoint. That does not mean the risk is absent. It means we have not looked hard enough yet.

And the rebound data - what happens when patients stop - is genuinely concerning. The STEP 4 trial showed that patients who discontinued semaglutide regained approximately two-thirds of their lost weight within one year. That is not a treatment effect. That is dependency. And if the drug is producing muscle and bone loss on the way down, and then weight regain on the way back up, the patient may end up in a worse body composition position than where they started.

We need to say that clearly.

The Emerging Case for a Different Approach

Here is where I want to stake a directional position, with full transparency that the data supporting it is still thin.

The standard GLP-1 dosing protocol is designed for maximum weight loss velocity. That is what the phase three trials optimized for. It is what got FDA approval. It is what the prescribing guidelines reflect.

But maximum velocity is not the same as optimal outcome.

Microdosing - using GLP-1 agonists at sub-therapeutic or low-therapeutic doses, with the explicit goal of slower, more controlled weight loss over a longer timeline - is being discussed seriously in metabolic medicine circles.

The hypothesis is straightforward: slower weight loss, combined with structured resistance training and adequate protein intake, preserves lean mass while still delivering meaningful metabolic improvement. You get the appetite regulation and the glucagon suppression without the aggressive body composition changes that come with rapid loss.

Is this proven? No. The long-term microdosing data does not exist yet. That is the honest answer. But the physiological rationale is sound, and it aligns with everything we know from the bariatric and sports medicine literature about how to lose weight without gutting your musculoskeletal architecture.

The framework I find compelling is this: GLP-1 drugs as a metabolic bridge, not a metabolic destination.

Use them to get appetite and blood sugar regulation under control. Use the lower-dose window to build the behavioral infrastructure - resistance training, protein targets, sleep, stress management - that has to exist for any weight loss to be sustainable. Then taper or maintain at the lowest effective dose, with the explicit goal of not being on maximum-dose semaglutide indefinitely.

This is not how most of these prescriptions are being written right now.

The Question Nobody Is Asking Their Prescriber

The patients flooding into primary care offices asking for Ozempic are not asking about lean mass. They are not asking about bone density trajectories. They are not asking what happens to their body composition at maximum dose over two years, or what the discontinuation curve looks like, or whether there is an alternative protocol that trades some speed for better structural outcomes.

They are asking: “Does it work?”

And the answer - based on the weight loss numbers alone - is yes.

But that is the wrong question.

The right question is:

Work for what?
Over what timeline?
At what cost to the rest of the body?

As physicians, we are responsible for asking the question the patient does not know to ask. That is not paternalism. That is clinical leadership.

The enthusiasm around GLP-1s is not wrong. The underlying science is promising and the cardiovascular outcome data from SELECT and LEADER trials is genuinely compelling. But promising is not the same as proven. And in medicine, moving from promising to proven requires time, rigor, and a willingness to slow down when the culture is sprinting.

What I Am Watching For

I am not prescribing a protocol here. I am not qualified to give individualized prescribing guidance in a newsletter, and anyone who tells you they have the definitive GLP-1 microdosing answer right now is outrunning the data.

What I am watching for - and what I think every clinician managing patients on these drugs should be tracking:

Body composition, not just body weight. Scale weight tells you almost nothing useful. DEXA scan or bioelectrical impedance at baseline and every six months tells you whether you are losing fat or muscle. If it is muscle, the protocol needs to change.

Resistance training as a non-negotiable co-intervention. The research on preserving lean mass during caloric restriction is unambiguous - resistance training is the primary tool. If a patient is on a GLP-1 and not lifting, they are losing muscle. Full stop.

Long-term outcome data as it emerges. The five and ten year studies are coming. I am reading them as they publish. The story this drug class tells at year two and the story it tells at year seven may be very different.

Honest conversations about discontinuation. If the plan is indefinite use, say so. If the plan is to taper, build that timeline in from day one with a clear protocol for maintaining outcomes.

The drug might work. The early data suggests it does - in the short term, at the doses tested, for the endpoints measured.

But medicine has a long history of enthusiasm outrunning evidence. HRT. Arthroscopic knee surgery for osteoarthritis. Opioids for chronic pain. In every case, the early data looked promising. The cultural momentum was real. And the full picture took years - sometimes decades - to emerge.

GLP-1s may be different. I genuinely hope they are.

But hope is not a clinical strategy.

Slow down. Measure everything. And do not let a cultural gold rush substitute for a longitudinal outcome.

That is the incision point.

What are your thoughts?

Have you or someone you know been using Ozempic?

Have you/they had success?

Has there been side effects?

We have a blind spot in modern medicine. We look at chronic disease and see “bad luck” or “genetics.” We treat inflammation like a symptom to be suppressed with medication.

But as a surgeon who works with metallurgy and biology, I don’t see inflammation. I see corrosion.

I’ve seen what happens when metal corrodes inside the human body. The tissue dies. It turns black. It necroticizes.

Here is the uncomfortable truth: You don’t need a metal implant to corrode. Chronic inflammation is the exact same process, just slower.

You are rusting from the inside out.

The Science of Corrosion (MACC)

Years ago, I published research on a phenomenon known as Metal-Associated Chemical Corrosion (MACC).

We investigated what happens when the modular junction of a hip replacement—where the ball meets the stem—undergoes “fretting.” If those two pieces of metal rub together under high stress, they release microscopic metal ions into the surrounding space.

The body identifies these ions as foreign invaders. The immune system launches a massive, scorched-earth attack. The result is a pseudotumor—a mass of fluid and dead tissue.

This is a biological reaction to an environmental irritant.

Why does this matter to you? Because Harvard Medical School has identified chronic inflammation as the common denominator in the four major killers: heart disease, cancer, diabetes, and Alzheimer’s.

The mechanism is identical to MACC. When you flood your system with processed sugars, seed oils, and stress hormones, you are introducing “ions” your body doesn’t recognize. Your immune system attacks your own vascular walls, your joints, and your brain tissue.

The “Car on Fire” Scenario

I saw this recently with a patient I’ll call Robert.

Robert came to me for a total knee replacement. He was 54, a high-performing executive, but he was in agony. He limped into the exam room, sweating, clearly uncomfortable.

Here was the engineering conflict: His X-rays didn’t match his pain. He had moderate arthritis, yes. But his pain levels were a 10/10. Structurally, his knee was a “flat tire.” But clinically, he was acting like the car had exploded.

I looked at his labs. His C-Reactive Protein (CRP)—a marker for systemic inflammation—was through the roof.

I told him the truth most surgeons won’t say: “Robert, I can replace the tire (your knee). But the car is on fire. If I operate on you right now, the risk of infection and failure is unacceptably high because your body is already fighting a war on three fronts.”

Robert was living on fast food, sleeping 4 hours a night, and drowning in cortisol. He wasn’t just “unhealthy.” He was an environment of rapid corrosion.

The Anti-Corrosion Protocol

We delayed surgery. We put him on what I call an Anti-Corrosion Protocol.

Six weeks later, he returned. He hadn’t had surgery yet. But his pain had dropped from a 10 to a 4.

Why? Because we stopped the rust. His joints were still arthritic (mechanical failure), but the surrounding tissue was no longer being attacked by his own immune system.

If you want to stop rusting, you have to treat your body like a high-performance alloy that needs environmental protection. Here are the 5 variables I control:

1. Eliminate the Oxidizers (Diet) Processed sugar is a biological accelerant. If your food has a shelf life of 5 years, your body treats it like a foreign object—just like those metal ions. Eat real fuel. If it didn’t grow or walk, don’t eat it.

2. Drain the Swamp (Lymphatics) Corrosion happens in stagnant environments. Unlike your heart, your lymphatic system (your waste removal piping) has no pump. It relies entirely on mechanical motion to clear waste. If you sit at a desk for 12 hours, you are stagnating. You need motion to flush the system.

3. Shut Down the Factory (Visceral Fat) Robert had significant belly fat. In medical school, we used to think fat was just stored energy. We now know that visceral fat is biologically active tissue. It acts like a gland, pumping inflammatory cytokines into your blood 24/7. Losing the gut isn’t vanity; it’s removing a toxic waste factory from your chassis.

4. Stop the Acid Rain (Cortisol) Chronic stress releases cortisol. In short bursts, it saves your life. In constant drips, it eats away at your sleep and recovery. You must have a mechanism to flush cortisol—exercise, meditation, or prayer.

5. The Maintenance Window (Sleep) You cannot repair a machine while it is running at redline. Deep sleep is the only time your brain cleans out metabolic waste (beta-amyloid). If you cut sleep, you skip the maintenance cycle.

The Bottom Line

Corrosion is a natural law of physics. Entropy dictates that things break down. But in the human body, the rate of corrosion is a choice.

Robert eventually got his knee replacement. He recovered in record time because his system was clean.

Are you coating your system, or are you letting it rust?

R. Michael Meneghini, MD

If you liked this, share it with someone who feels “achy” all over but can’t pinpoint why. Next week, we are diving into “The Stability Paradox”…

why adding complexity to a system often increases the risk of failure.

We have a language problem in medicine. We tell patients they “have” arthritis, as if it’s a virus they caught or a genetic curse they inherited. We treat it like a disease.

But as an engineer, I don’t see a disease. I see a mechanical failure.

Your knees didn’t just “get old.” They failed because the load vectors crossing the joint were out of tolerance. They failed because the coefficient of friction, which in a healthy joint is five times slicker than ice on ice, was compromised by eccentric loading.

You aren’t sick. You are misaligned.

Thanks for reading The Incision Point! Subscribe to help disrupt the status quo.

The Physics of Failure

In a study we published on femoral stem fixation (Inadequate Metadiaphyseal Fill of a Modern Taper-Wedge Stem), we looked at what happens when an implant doesn’t perfectly match the geometry of the bone.

When a hip stem is undersized or misaligned, it doesn’t just sit there. It subsides. It moves. The axial load of walking isn’t transferred evenly; it creates shear forces that destroy the interface between metal and bone.

The exact same physics applies to your native knee.

A healthy knee is designed to distribute load across two compartments (medial and lateral). It is an optimized load-bearing system. But if you have a slight varus (bow-legged) deformity, you are no longer distributing load evenly. You are point-loading the medial compartment.

It’s the difference between driving a car with perfect alignment and driving one where the tires are angled inward. It doesn’t matter how expensive the tires are; they will blow out after 10,000 miles. That isn’t “tire disease.” That is mechanical reality.

Tolerance Stacking

In engineering, we talk about “tolerance stacking,” when small deviations in multiple parts add up to a catastrophic failure.

In the human machine, arthritis is often the result of tolerance stacking:

1. Static Alignment: You have a mild structural deformity (varus/valgus).

2. Dynamic Weakness: Your glutes are weak, causing your femur to rotate internally during gait.

3. Excess Load: You are carrying an extra 30 pounds.

Individually, the system might handle these. Stacked together, they exceed the material properties of the cartilage. The friction coefficient skyrockets. The surface degrades.

We call this “Osteoarthritis.” I call it Cycle-Dependent Fatigue Failure.

Re-Engineering Your Chassis

Why does this distinction matter? Because you can’t “cure” a mechanical failure with a pill. You have to fix the mechanics.

If you want to preserve your joints (or your replacement joints), you have to think like a structural engineer.

• Reduce the Axial Load: Every pound of body weight places 4 to 6 pounds of force on the knee joint. Losing 10 pounds isn’t just cosmetic; it reduces the mechanical load on your knees by 40,000 to 60,000 pounds per mile walked. That is massive structural relief.

• Balance the Tension: Your muscles are the guy-wires holding the mast straight. If your quadriceps are weak or your hamstrings are tight, the joint tracks poorly. You are grinding the gears every time you take a step. Strengthening the “engine” (muscle) protects the “chassis” (bone).

• Respect the Envelope: Just like the implants I design, your joints have a specific range of motion where they function optimally. Pushing them repetitively outside that envelope, through poor form in the gym or bad posture at your desk, is asking for failure.

The Bottom Line

Stop waiting for a “cure” for arthritis. The cure is physics.

If you treat your body like a machine that requires alignment, lubrication, and load management, you can extend its warranty significantly. If you ignore the mechanics, you will eventually end up on my operating table.

And while I am very good at replacing the parts, the original equipment, when properly maintained, is still the best engineering on the planet.

R. Michael Meneghini, MD

If you liked this, share it with someone who complains about their “bad knees” but hasn’t looked at their mechanics. Next, I’m discussing “The ‘Rust’ Inside Us”, why inflammation is actually biological corrosion.

Thanks for reading The Incision Point! Subscribe to help disrupt the status quo.

Most people think of “healing” as a passive activity. You lie in bed. You watch Netflix. You wait for the body to knit itself back together.

From an engineering perspective, this is dangerously inaccurate.

Healing isn’t passive rest. It is a metabolic fire. When you undergo surgery, run a marathon, or suffer a major trauma, your body doesn’t shut down to repair itself, it revs up. It enters a state of hyper-metabolism to meet the massive energy demands of reconstruction.

If you don’t feed that fire with the right fuel, your body will do what any survival machine does: it will start burning its own infrastructure to keep the lights on.

This is the Catabolic Crisis. And whether you are a patient recovering from a total knee replacement or an executive recovering from burnout, you need to understand the physics of it.

The 3-8 Day Window

In a review we published on infection prevention (Extended Oral Antibiotics in Primary and Revision Total Joint Arthroplasty), we discussed a critical physiological window.

After a major surgery like a hip or knee replacement, the body enters a catabolic state that typically lasts for 3 to 8 days.

During this phase, the body’s systemic response ramps up exponentially. It is recruiting white blood cells, synthesizing proteins, and laying down collagen matrix. This requires a massive amount of ATP (energy).

If the body doesn’t have enough available protein and glucose circulating in the blood, it turns to its internal reserves. It doesn’t burn fat first (which is slow to convert); it burns muscle. It breaks down the very quadriceps and glutes we are trying to rehabilitate to harvest the amino acids necessary for survival.

You aren’t just “tired” after surgery. Your body is literally eating its own muscle to survive the trauma.

The “Golden Period” of Defense

This catabolic state is also why infection risk is highest in the first week. We call this the “Golden Period”.

During this time, the immune system is overwhelmed. The bacterial burden is fighting against the host’s defenses. If the host is in a severe catabolic deficit, malnourished, anemic, or depleted, the immune system acts like an engine running on fumes. It stalls.

This is why we implemented Extended Oral Antibiotic Prophylaxis (EOAP) for high-risk patients. We aren’t just throwing drugs at a problem; we are engineering a bridge to support the immune system while it is mechanically overloaded.

Engineering Your Recovery

So, how do we solve this energy problem? We stop treating nutrition as “wellness” and start treating it as “input variables.”

1. Pre-Operative Loading: You wouldn’t drive a race car onto the track with an empty tank. We optimize hemoglobin and nutrition before the first incision. If you go into surgery with an empty tank (anemia/malnutrition), you will crash during the catabolic phase.

2. Protein is Structural Integrity: During the catabolic window, protein intake isn’t about “gains”; it’s about preventing structural collapse. You need to flood the system with amino acids so the body burns your lunch instead of your legs.

3. Minimize the Trauma: This brings us back to surgical technique. The less tissue we damage (no tourniquets, precise muscle-sparing approaches), the smaller the metabolic fire we ignite. A smaller fire requires less fuel to manage.

The Human Machine Application

This principle applies to everyone, not just surgical patients.

If you are training for an Ironman, or if you are launching a startup and sleeping 4 hours a night, you are inducing a catabolic state. You are creating micro-trauma.

If you don’t engineer your recovery with the same intensity that you engineer your work, you will hit the Catabolic Crisis. Your performance won’t just plateau; your internal structure will degrade. You will get sick. You will get injured. You will burn out.

The Bottom Line

Recovery is an active, energy-expensive process. It requires fuel. It requires strategy.

Don’t mistake “resting” for “healing.” One is doing nothing; the other is the most metabolically demanding thing your body can do.

Respect the physics of your own biology.

R. Michael Meneghini, MD

If you liked this, share it with someone who thinks skipping meals is a “productivity hack.” Next, I’m diving into “Friction Coefficients”, why arthritis isn’t a disease of aging, but a mechanical failure of alignment.

A Ferrari Engine in a Rusted Frame

We are obsessed with “longevity.” Billions of dollars are spent every year on bio-hacking, heart health, and anti-aging protocols. We have become very good at keeping the human engine running.

Modern medicine can keep your heart beating, your lungs breathing, and your blood flowing well into your 90s. But nobody is talking about the frame.

I see the result of this imbalance every week in my clinic. I see 85-year-olds with the heart of a lion and the mind of a CEO, but they are trapped in a wheelchair because their hips and knees have mechanically failed.

They have “Lifespan.” They do not have “Mobility Span.”

If you live to be 100, but you cannot get off the toilet by yourself, you are not free. You are a prisoner in your own body. It is time to extend the warranty on your frame.

The “Out of Warranty” Phase

From an engineering perspective, the human machine comes with a factory warranty of about 30 to 40 years. After that, the structural integrity begins to degrade automatically unless you intervene.

According to the National Institutes of Health (NIH), after age 30, you begin to lose muscle mass at a rate of 3% to 5% per decade. By the time you reach 60, you may have lost nearly a third of your structural support. This isn’t just “getting weaker.” This is the bolts loosening on the chassis. As the muscle (the shock absorbers) withers away, the load is transferred directly to the bones and joints.

Once you pass 50, you are operating in the “Extended Maintenance Phase.” Biology is no longer doing the repair work for free. You have to manually input the maintenance. If you treat your machine at 60 the way you treated it at 20, you will experience catastrophic structural failure.

The Ultimate Metric: The Floor Test

I don’t care how fast you can run a mile. I care if you can save your own life. There is a simple test that is a shockingly accurate predictor of all-cause mortality. It’s called the Sit-to-Rise Test.

The Test:

1. Stand in the middle of a room (no chairs, no walls).

2. Sit down cross-legged on the floor.

3. Stand back up.

The Rules:

• You start with 10 points.

• Subtract 1 point for every support you use (hand, knee, forearm, side of leg).

• Subtract 0.5 points if you lose your balance.

If you score below an 8, the European Journal of Preventive Cardiology found you are two times more likely to die in the next 6 years compared to someone who scores perfectly. Why? Because this test measures the three pillars of an independent machine: Balance, Mobility, and Power.

If you cannot get off the floor without using your hands today, your machine is already failing. You are statistically likely to lose your independence within the decade.

Pre-Hab: Fixing the Roof While the Sun is Shining

Most patients come to me for “Rehab” after the surgery. But the people who win, the ones who are skiing at 80, practice “Pre-Hab.”

They treat their body like a classic car restoration project before the rust sets in.

1. Respect Wolff’s Law Wolff’s Law states that bone grows in response to the load placed upon it. If you stop lifting heavy things, your bones literally dissolve (osteopenia). You don’t lift weights to get “buff”; you lift weights to signal your skeleton that it is still needed.

2. Grease the Groove Cartilage has no blood supply. It gets its nutrients through imbibition, a process where movement squishes fluid in and out of the joint like a sponge. If you sit for 8 hours, your joints are starving. “Motion is Lotion” isn’t a rhyme; it’s a physiological fact. You need to take every joint through its full range of motion every single day to feed the bearings.

3. The Anti-Fragile Mindset Don’t stop moving because you have a little pain. Adjust the movement, but never stop. The moment you decide “I’m too old to squat” is the moment you begin the slide toward the wheelchair.

The Goal is Independence

I love performing hip and knee replacements. It is the most successful surgery in all of medicine. We can give you a new lease on life in 55 minutes.

But the best implant in the world is the one you were born with.

Your goal should not just be to live to 100. Your goal should be to walk out of your 100th birthday party on your own two feet.

R. Michael Meneghini, MD

Call to Action: Try the Floor Test tonight. Be honest with your score. If you scored less than an 8, it’s time to start “Pre-Hab.” Reply to this email with your score, I want to see where we stand.

Share The Incision Point

Your knees are 100 times slicker than ice.

This is a physics fact that most people, even some doctors, don’t appreciate.

The coefficient of friction for ice sliding on ice is about 0.1. The coefficient of friction for healthy human cartilage is approximately 0.001.

That means the bearings inside your knees and hips are nearly frictionless. They are engineering marvels designed to last for 100 years of heavy use without wearing out.

So, why do I have a 6-month waitlist of patients who need them replaced at age 55?

It isn’t because they “used them too much.” It isn’t because of “bad genetics.” It is almost always a problem of physics.

Welcome to The Human Machine. Today, we are talking about Friction.

The 4x Force Multiplier

To understand why the machine breaks, you have to understand the load it carries.

According to Harvard Health, the mechanics of walking create a massive force multiplier. For every one pound of body weight, your knees absorb four pounds of pressure. That means if you are just 10 pounds overweight, your knees aren’t carrying 10 extra pounds, they are carrying 40 extra pounds of load with every single step.

Now, apply that math to a misaligned machine. If your alignment is off by just a few millimeters, that massive compounded force isn’t being distributed evenly across the joint surface. It is being concentrated like a laser beam on one specific spot of cartilage.

That is how you grind a hole in a bearing that is supposed to be indestructible.

The Race Car Tire Analogy

I want you to stop thinking like a patient and start thinking like a mechanic.

Imagine you buy a brand new Ferrari. You drive it off the lot, but the front right wheel is misaligned by just 3 degrees. You can drive that car for 500 miles and everything will feel fine. But at mile 5,000, that tire will be bald on the inside edge.

Did the tire fail because it was “old”? No. The other three tires are brand new. Did it fail because you “drove too fast”? No. The tire is rated for 200 mph. It failed because misalignment converts rolling energy into shear force.

This is exactly what happens in the human knee. When your hip stabilizers are weak, your femur rotates internally. When your femur rotates, your knee track shifts. Now, instead of gliding on that slick 0.001 surface, you are grinding against the edge of the bearing under 4x the normal load.

Arthritis is not a disease of aging. Arthritis is a mechanical failure caused by uneven loading.

The Check Engine Light

In a car, a light pops up on the dashboard when the oil pressure drops. In the human machine, the “Check Engine Light” is subtle, and most of you are ignoring it.

It’s called Start-Up Pain.

• Do you feel stiff for the first 10 steps when you get out of bed?

• Do you have to “shake it out” when you stand up after a 2-hour flight?

• Does your knee ache only when you go down stairs?

That is not “getting old.” That is your machine telling you that your alignment is off. That is the sound of your tires scrubbing the pavement.

If you ignore the light, you eventually blow the engine. In my world, that means you end up on my operating table.

The 5-Minute Inspection

You don’t need an MRI to check your alignment. You just need a floor. Here are the two tests I use to determine if a patient’s mechanics are compromised.

Test 1: The Terminal Knee Extension (The Lockout)

A healthy knee should not just straighten; it should hyperextend slightly (about 5 degrees). This “locking out” mechanism allows your leg to become a rigid pillar, resting on bone rather than muscle.

The Test:

1. Sit on the floor with your legs out straight.

2. Place a rolled-up towel under your ankle.

3. Push your knee down toward the floor.

Pass: Your knee touches the floor comfortably. Fail: There is a gap, or it feels “stuck.” The Fix: If you can’t lock out, your quad is constantly firing just to keep you upright. You are driving with the parking brake on. You need to relentlessly stretch the posterior capsule (back of the knee) until you get that range back.

Test 2: Hip Internal Rotation (The Windshield Wiper)

The hip is a ball-and-socket joint. It is designed to rotate. If it stops rotating, that torque has to go somewhere. Usually, it goes downstream to your knee or upstream to your lower back.

The Test:

1. Sit on a chair with your knees bent at 90 degrees.

2. Keep your knees touching.

3. Swing your feet outward as far as you can (like windshield wipers moving apart).

Pass: Your feet swing out 35–45 degrees. Fail: You can barely move them, or you have to lift your hip to do it. The Fix: If your hips are stiff, your knees are taking a beating with every step. You need to mobilize the hip capsule. (We will cover specific protocols for this in Part 4 of this series).

Maintenance vs. Replacement

I am a surgeon. I make my living replacing parts. But I am also an engineer, and I hate seeing a good machine go to waste because of poor maintenance.

If you have “bad knees,” stop blaming your age. Look at your alignment. Check your tire pressure. Fix the friction.

And if you do need the replacement? Well, we’ve engineered that process to take 55 minutes. But I’d rather you keep your original parts as long as possible.

Next week: We are looking at the engine. Why I sleep 5 hours a night, perform 1,000 surgeries a year, and have more energy now than I did at 30.

R. Michael Meneghini, MD

Call to Action: Try the “Lockout Test” right now. If you fail, you have homework. Share this with a friend who complains about their “bad knees.”

Share The Incision Point